Get 30% Free Customization on This Report

Published Date: July, 2019

Viral Vector and Plasmid DNA Manufacturing Market (Type - Adenovirus, Lentivirus, Adeno-associated Virus, Plasmid DNA, and Other Type; Application - Gene Therapy, Vaccinology, and Other Applications; Disease - Cancer, Genetic Disorders, Infectious Disease, and Other Disease; End-user - Biotech Companies, and Research Institutes): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025


Request Discount Enquire Before Buying

A recent report published by Infinium Global Research on viral vector and plasmid DNA manufacturing market provides an in-depth analysis of segments and sub-segments in the global as well as regional viral vector and plasmid DNA manufacturing market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional viral vector and plasmid DNA manufacturing market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global viral vector and plasmid DNA manufacturing market. According to the report, the global viral vector and plasmid DNA manufacturing market is projected to grow at a CAGR of 16.2% over the forecast period of 2019-2025.

 

Market Insight

The rise in incidence rates of cancer is one of the major drivers that drives the growth of the viral vector and plasmid DNA manufacturing market across the globe. According to Cancer Research UK, nearly 17 million new cases of cancer were there in 2018. The four most common types of cancer worldwide are lung, breast, bowel, and prostate cancers, which account for about 43% of all new cases. Furthermore, genetic disorders and infectious diseases also fuel the growth of the market globally. High unmet needs in patients with rare disorders and raised acceptance for comparatively newer treatment options in developing countries are expected to boost the viral vector & plasmid DNA manufacturing market during the forecast period. However, the high cost of gene therapies may restrain the growth of the market of viral vector & plasmid DNA manufacturing. Moreover, the untapped potential of emerging countries creates an opportunity for the growth of the market in the next few years.

 

In terms of region, the viral vector & plasmid DNA manufacturing market has been categorized into North America, Europe, Asia-Pacific, and the Rest of the World. North America is leading the global viral vector and plasmid DNA manufacturing market and is estimated to dominate the market growth over the forecast period. This is attributed to the high adoption of viral vector-based products in the United States. The growing rate of cancer and monogenic disorders, rich product pipeline, and technological advancements in the region drives the growth of the viral vector and plasmid DNA manufacturing market in the North American region. The market in the Asia Pacific is expected to grow at a rapid speed over the forecast period. This is attributed to the increased research initiatives in countries like India and the availability of approved gene therapies based on viral vectors in countries such as China and Japan.

 

Segment Covered

The report on global viral vector and plasmid DNA manufacturing market covers segments such as type, application, disease, and end-user. On the basis of type, the sub-markets include adenovirus, lentivirus, adeno-associated virus, plasmid DNA, and other type. On the basis of application, the sub-markets include gene therapy, vaccinology, and other applications. On the basis of disease, the sub-markets include cancer, genetic disorders, infectious disease, and other disease. On the basis of end-user, the sub-markets include biotech companies, and research institutes.

 

Companies Profiled:

The report provides profiles of the companies in the market such as CobraBiologics, Novasep Inc., Cell and Gene Therapy Catapult, Kaneka Eurogentec S.A., FUJIFILM Diosynth Biotechnologies Inc., Spark Therapeutics, Inc., Merck KGaA, uniQure N.V., and Lonza.

 

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of viral vector and plasmid DNA manufacturing market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.

The Infinium Advantages

Analyst Support

Get free analyst support for the queries before and post purchasing report.

Customer Satisfaction

Be assured of 100% customer satisfaction about the research and get 24X7 customer support.

400% Growth

Infinium has achieved over 400%+ growth in its repository and revenue over the last 2 years. Yes, we are proud to say we are growing at a great pace and becoming a trusted partner among our clients.

Related Reports

sign up for our newsletter